Zoetis stock slips despite deal for Neogen genomics unit, BofA and Leerink React

Investing.com Gold reports: Zoetis stock slips despite deal for Neogen genomics unit, BofA and Leerink React. This is a premium/paywalled source, so the brief is based on headline and available metadata only.